US2006106116A1PendingUtilityA1
Composition for lessening oxidative stress
Est. expiryOct 12, 2021(expired)· nominal 20-yr term from priority
A61P 43/00A61K 31/085A61K 31/122A61P 39/06
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for lessening oxidative stress in vivo in a subject in need thereof, comprising administering to said subject a composition containing a reduced coenzyme Q and an oxidized coenzyme of Q.
Claims
exact text as granted — not AI-modified1 . A method for lessening oxidative stress in vivo in a subject in need thereof, comprising administering to said subject a composition containing a reduced coenzyme Q of formula (2) and an oxidized coenzyme Q of formula (1):
(wherein n represents an integer from 1 to 12);
(wherein n represents an integer from 1 to 12).
2 . The method according to claim 1 , wherein the coenzyme Q is coenzyme Q 10 .
3 . A method of reducing oxidative stress in viva associated with a disease comprising administering to a subject a composition containing a reduced coenzyme Q antioxidant of formula (2) and an oxidized coenzyme Q of formula (1):
(wherein n represents an integer from 1 to 12);
(wherein n represents an integer from 1 to 12).
4 . The method according to claim 2 , wherein the coenzyme Q is coenzyme Q 10 .
5 . A method according to claim 2 , wherein the reduced and oxidized coenzyme Q are administered to a human in a total dose per kg of weight of a human body of 0.1 mg/day to 500 mg/day.
6 . A method according to claim 2 , wherein the reduced and oxidized coenzyme Q are administered to a human in a total dose per kg of weight of a human body of 1 mg/day to 100 mg/day.
7 . A method according to claim 2 , wherein the reduced and oxidized coenzyme Q are administered to a human in a total dose per kg of weight of a human body of 2 mg/day to 75 mg/day.
8 . A method for reducing oxidative stress in vivo due to a skin disease comprising externally administering to a subject a composition containing a reduced coenzyme Q of formula (2) and an oxidized coenzyme Q of formula (1):
(wherein n represents an integer from 1 to 12);
(wherein n represents an integer from 1 to 12).
9 . The method according to claim 8 , wherein the coenzyme Q is coenzyme Q 10 .
10 . A method for lessening oxidative stress in vivo in a subject in need thereof, comprising administering to said subject a composition containing a reduced coenzyme Q of formula (2):
(wherein n represents an integer from 1 to 12).
11 . The method according to claim 10 , wherein the coenzyme Q is coenzyme Q 10 .
12 . A method for reducing oxidative stress in vivo due to a disease comprising administering to a subject a composition containing a reduced coenzyme Q antioxidant of formula (2):
(wherein n represents an integer from 1 to 12).
13 . The method according to claim 12 , wherein the coenzyme Q is coenzyme Q 10 .
14 . A method according to claim 12 , wherein the reduced coenzyme Q is administered to a human in dose per kg of weight of a human body of 0.1 mg/day to 500 mg/day.
15 . A method according to claim 12 , wherein the reduced coenzyme Q is administered to a human in dose per kg of weight of a human body of 1 mg/day to 100 mg/day.
16 . A method according to claim 12 , wherein the reduced coenzyme Q is administered to a human in dose per kg of weight of a human body of 2 mg/day to 75 mg/day.
17 . A method for treating reducing oxidative stress in vivo due to a skin disease comprising externally administering to a subject a composition containing a reduced coenzyme Q of formula (2):
(wherein n represents an integer from 1 to 12).
18 . The method according to claim 17 , wherein the coenzyme Q is coenzyme Q 10 .Join the waitlist — get patent alerts
Track US2006106116A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.